Called Transforming IBD Care, the challenge focuses on innovation in IBD monitoring, condition management or care enhancements.
The early-stage study took place over 12 weeks and included an 82-person healthy control group and 31 individuals with varying stages of cognitive decline.
The platform has been expanded to include connected devices and digital therapeutic solutions for patients with diabetes, asthma, and COPD.
The new platform offers transparent pricing for dental care and allows consumers to book and pay for professional services from a mobile app.
New business unit to help meet the hearing health needs of people enrolled in UnitedHealthcare individual, employer-sponsored and Medicare Advantage plans.
The new feature brings push health nudges and personalized health insights to smartphone users with chronic conditions.
Flow Neuroscience has invented a new, medication-free treatment for depression, comprised of a brain stimulation headset and therapy app.
The company's implantable system is the only long-term CGM that lasts up to 90 days; it is now available for $99 plus the cost of the sensor placement.
The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
Under the deal, Orion's existing line of Easyhaler products will connect to Propeller's digital medicine platform via a small, custom-built sensor.